Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

NCT02049190 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Metastatic Prostate Cancer
Androgen-independent Prostate Cancer
Recurrent Prostate Cancer

Interventions

DRUG: onapristone
DRUG: abiraterone

Sponsor

Arno Therapeutics